This text is a result of machine translation.
Italy plans to negotiate a single network project with EU officials.
Beishang capital continued to rush to raise a shares, accumulating a net purchase of 1696.1 billion, a record high
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Yesterday 12:13 PM
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
Mask protection unit rose in the afternoon
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Robust medical: by the end of October, 1159400 shares had been repurchased
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
Xinxiang Chemical Fiber: some production workshops of viscose filament are temporarily shut down due to water inflow
Bank of America: once the BoJ policy turns to the fair value of the yen, it will provide support for the exchange rate
235 monkeypox cases confirmed in Canada
IMF President Georgieva said that policies were needed to curb the rise in oil prices.
IMF lowered the US economic growth forecast for 2022 from 3.7% to 2.9%
Fledgling Players, Top-selling Products: China's Smart Home Industry in 2022
Jun 23, 2022 11:14 AM